Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss
Anna Thorsø Larsen, M.A. Karsdal, Kim Henriksen
Topics & Concepts
SemaglutideAmylinAgonistEndocrinologyMedicineInternal medicineCalcitonin receptorCalcitoninReceptorPartial agonistChemistryPharmacologyCalcitonin gene-related peptideLiraglutideDiabetes mellitusType 2 diabetesNeuropeptideIsletDiabetes Treatment and ManagementNeuropeptides and Animal PhysiologyAdipokines, Inflammation, and Metabolic Diseases